Cargando…
Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B
Glucocorticoids are widely used in conjunction with chemotherapy for ovarian cancer to prevent hypersensitivity reactions. Here we reveal a novel role for glucocorticoids in the inhibition of ovarian cancer metastasis. Glucocorticoid treatments induce the expression of miR-708, leading to the suppre...
Autores principales: | Lin, Kai-Ti, Yeh, Yu-Ming, Chuang, Chi-Mu, Yang, Scarlett Y., Chang, Jer-Wei, Sun, Shu-Pin, Wang, Yi-Shiang, Chao, Kuan-Chong, Wang, Lu-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354140/ https://www.ncbi.nlm.nih.gov/pubmed/25569036 http://dx.doi.org/10.1038/ncomms6917 |
Ejemplares similares
-
MicroRNA-708 emerges as a potential candidate to target undruggable NRAS
por: Pang, Jia Meng, et al.
Publicado: (2023) -
Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model
por: Lin, Kai-Ti, et al.
Publicado: (2017) -
MicroRNA‐708‐3p mediates metastasis and chemoresistance through inhibition of epithelial‐to‐mesenchymal transition in breast cancer
por: Lee, Jin‐Won, et al.
Publicado: (2018) -
Synergistic effects of miR-708-5p and miR-708-3p accelerate the progression of osteoporosis
por: Wang, Ruran, et al.
Publicado: (2020) -
LINC00665 Facilitates the Malignant Processes of Osteosarcoma by Increasing the RAP1B Expression via Sponging miR-708 and miR-142-5p
por: Wang, Limin, et al.
Publicado: (2021)